Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Dobson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Occupational Medicine (Oxford, England)|December 31, 2008
How can revalidation help to tackle local concerns about doctors' health?Ruth Chambers, Lucy Warner, Charles Dobson
Neuroimage|August 23, 2011
Evaluative and generative modes of thought during the creative processMelissa Ellamil, Charles Dobson, Mark Beeman, et al.
BMJ (Clinical Research Ed.)|December 4, 2009
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparatorMike Boggild, Jackie Palace, Pelham Barton, et al.
BMJ Open|January 21, 2014
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov modelJacqueline Palace, Thomas Bregenzer, Helen Tremlett, et al.
The Lancet. Neurology|April 6, 2015
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparatorJacqueline Palace, Martin Duddy, Thomas Bregenzer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 23, 2018
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing schemeJacqueline Palace, Martin Duddy, Michael Lawton, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Occupational Medicine (Oxford, England)|December 31, 2008
How can revalidation help to tackle local concerns about doctors' health?Ruth Chambers, Lucy Warner, Charles Dobson
Neuroimage|August 23, 2011
Evaluative and generative modes of thought during the creative processMelissa Ellamil, Charles Dobson, Mark Beeman, et al.
BMJ (Clinical Research Ed.)|December 4, 2009
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparatorMike Boggild, Jackie Palace, Pelham Barton, et al.
BMJ Open|January 21, 2014
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov modelJacqueline Palace, Thomas Bregenzer, Helen Tremlett, et al.
The Lancet. Neurology|April 6, 2015
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparatorJacqueline Palace, Martin Duddy, Thomas Bregenzer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 23, 2018
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing schemeJacqueline Palace, Martin Duddy, Michael Lawton, et al.
Pageof 1